Ning Huangfu

641 total citations
26 papers, 451 citations indexed

About

Ning Huangfu is a scholar working on Molecular Biology, Immunology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Ning Huangfu has authored 26 papers receiving a total of 451 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 9 papers in Immunology and 6 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Ning Huangfu's work include Atherosclerosis and Cardiovascular Diseases (6 papers), RNA Research and Splicing (4 papers) and Adipokines, Inflammation, and Metabolic Diseases (3 papers). Ning Huangfu is often cited by papers focused on Atherosclerosis and Cardiovascular Diseases (6 papers), RNA Research and Splicing (4 papers) and Adipokines, Inflammation, and Metabolic Diseases (3 papers). Ning Huangfu collaborates with scholars based in China, United States and Sweden. Ning Huangfu's co-authors include Wenyuan Zheng, Xiaohong Chen, Ruochi Zhao, Shuangshuang Zhang, Fu-Xing Zhang, Dandan Zhang, Zhenyu Xu, Yong Wang, Yong Wang and Zhenyu Xu and has published in prestigious journals such as Biochemical and Biophysical Research Communications, Autophagy and Current Pharmaceutical Design.

In The Last Decade

Ning Huangfu

22 papers receiving 447 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ning Huangfu China 9 247 142 108 88 58 26 451
Lang Shi China 12 250 1.0× 116 0.8× 83 0.8× 67 0.8× 23 0.4× 24 448
Sujuan Xu China 13 180 0.7× 52 0.4× 110 1.0× 50 0.6× 32 0.6× 29 406
Xiaoqiang Ding China 10 190 0.8× 200 1.4× 84 0.8× 54 0.6× 21 0.4× 14 411
Mária Godó Hungary 10 237 1.0× 130 0.9× 133 1.2× 76 0.9× 42 0.7× 18 478
Naoko Yokota‐Ikeda Japan 12 275 1.1× 57 0.4× 175 1.6× 76 0.9× 23 0.4× 17 526
Shiyuan Wu China 8 557 2.3× 127 0.9× 125 1.2× 168 1.9× 75 1.3× 10 691
Beilei Zhao China 11 197 0.8× 40 0.3× 106 1.0× 30 0.3× 29 0.5× 20 430
Ze Bo Hu China 12 181 0.7× 33 0.2× 139 1.3× 67 0.8× 40 0.7× 19 464
Zongwei Lin China 10 204 0.8× 90 0.6× 20 0.2× 74 0.8× 69 1.2× 19 388

Countries citing papers authored by Ning Huangfu

Since Specialization
Citations

This map shows the geographic impact of Ning Huangfu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ning Huangfu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ning Huangfu more than expected).

Fields of papers citing papers by Ning Huangfu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ning Huangfu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ning Huangfu. The network helps show where Ning Huangfu may publish in the future.

Co-authorship network of co-authors of Ning Huangfu

This figure shows the co-authorship network connecting the top 25 collaborators of Ning Huangfu. A scholar is included among the top collaborators of Ning Huangfu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ning Huangfu. Ning Huangfu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Pan, Ziwei, Ning Huangfu, Fangkun Yang, et al.. (2025). Excessive autophagic degradation of MYLK3 causes sunitinib-induced cardiotoxicity. Autophagy. 21(12). 2730–2749.
3.
Cui, Hanbin, et al.. (2023). Causal association between sleep traits and the risk of coronary artery disease in patients with diabetes. Frontiers in Cardiovascular Medicine. 10. 1132281–1132281. 1 indexed citations
4.
Wang, Xizhi, et al.. (2023). Superfamily II helicases: the potential therapeutic target for cardiovascular diseases. Frontiers in Cardiovascular Medicine. 10. 1309491–1309491.
5.
Yang, Fangkun, et al.. (2023). Apolipoprotein B and interleukin 1 receptor antagonist: reversing the risk of coronary heart disease. Frontiers in Endocrinology. 14. 1278273–1278273. 2 indexed citations
6.
Cui, Hanbin, et al.. (2023). Increased selenium and decreased iron levels in relation to risk of coronary artery disease in patients with diabetes. Frontiers in Nutrition. 10. 1103330–1103330. 2 indexed citations
8.
Huangfu, Ning, et al.. (2023). Genetic liability to mental disorders in relation to the risk of hypertension. Frontiers in Cardiovascular Medicine. 10. 1087251–1087251. 6 indexed citations
9.
Huangfu, Ning, et al.. (2022). The First Biological Portrait of Stalk-Eyed Fruit Flies: Life History, Reproductive Biology and Host Use Patterns in Pelmatops spp. (Diptera: Tephritidae). Annals of the Entomological Society of America. 115(5). 365–377. 1 indexed citations
10.
Yang, Fangkun, Ning Huangfu, Zihao Qu, et al.. (2022). Genetic liability to sedentary behavior in relation to myocardial infarction and heart failure: A mendelian randomization study. Nutrition Metabolism and Cardiovascular Diseases. 32(11). 2621–2629. 4 indexed citations
11.
Huangfu, Ning, et al.. (2022). Notes on the Genus Aceratoneuromyia Girault (Hymenoptera: Eulophidae). Insects. 13(5). 450–450. 2 indexed citations
12.
Huangfu, Ning, et al.. (2022). Exploring the Effect and Mechanism of Si-Miao-Yong-An Decoction on Abdominal Aortic Aneurysm Based on Mice Experiment and Bioinformatics Analysis. Evidence-based Complementary and Alternative Medicine. 2022. 1–15. 2 indexed citations
13.
Li, Zhenwei, et al.. (2021). Mettl3 promotes oxLDL‐mediated inflammation through activating STAT1 signaling. Journal of Clinical Laboratory Analysis. 36(1). e24019–e24019. 30 indexed citations
14.
Huangfu, Ning, Yong Wang, Zhenyu Xu, et al.. (2021). TDP43 Exacerbates Atherosclerosis Progression by Promoting Inflammation and Lipid Uptake of Macrophages. Frontiers in Cell and Developmental Biology. 9. 687169–687169. 25 indexed citations
15.
Wang, Shiqi, et al.. (2020). Long non-coding RNA BANCR promotes interferon-β-induced cardiomyocyte apoptosis by targeting signal transducer and activator of transcription 1 in vitro.. PubMed. 13(11). 2840–2852. 3 indexed citations
16.
Huangfu, Ning, Wenyuan Zheng, Zhenyu Xu, et al.. (2020). RBM4 regulates M1 macrophages polarization through targeting STAT1-mediated glycolysis. International Immunopharmacology. 83. 106432–106432. 62 indexed citations
17.
Zheng, Nan, Ning Huangfu, Mei Li, et al.. (2019). Association ofGCKgene DNA methylation with the risk of clopidogrel resistance in acute coronary syndrome patients. Journal of Clinical Laboratory Analysis. 34(2). e23040–e23040. 8 indexed citations
18.
Chu, Lin, et al.. (2018). Effect of Shexiang Tongxin Dropping Pills (麝香通心滴丸) on the Immediate Blood Flow of Patients with Coronary Slow Flow. Chinese Journal of Integrative Medicine. 25(5). 360–365. 17 indexed citations
19.
Huangfu, Ning, et al.. (2017). LncRNA MALAT1 regulates oxLDL-induced CD36 expression via activating β-catenin. Biochemical and Biophysical Research Communications. 495(3). 2111–2117. 60 indexed citations
20.
Huangfu, Ning, et al.. (2017). Neat1 regulates oxidized low-density lipoprotein-induced inflammation and lipid uptake in macrophages via paraspeckle formation. Molecular Medicine Reports. 17(2). 3092–3098. 44 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026